American Society for Gastrointestinal Endoscopy guideline on endoscopic submucosal dissection for the management of early esophageal and gastric cancers: methodology and review of evidence.


Journal

Gastrointestinal endoscopy
ISSN: 1097-6779
Titre abrégé: Gastrointest Endosc
Pays: United States
ID NLM: 0010505

Informations de publication

Date de publication:
09 2023
Historique:
received: 06 03 2023
accepted: 24 03 2023
medline: 21 8 2023
pubmed: 27 7 2023
entrez: 27 7 2023
Statut: ppublish

Résumé

This document from the American Society for Gastrointestinal Endoscopy (ASGE) provides a full description of the methodology used in the review of the evidence used to inform the final guidance outlined in the accompanying Summary and Recommendations document regarding the role of endoscopic submucosal dissection (ESD) in the management of early esophageal and gastric cancers. This guideline used the Grading of Recommendations, Assessment, Development and Evaluation framework and specifically addresses the role of ESD versus EMR and/or surgery, where applicable, for the management of early esophageal squamous cell carcinoma (ESCC), esophageal adenocarcinoma (EAC), and gastric adenocarcinoma (GAC) and their corresponding precursor lesions. For ESCC, the ASGE suggests ESD over EMR for patients with early-stage, well-differentiated, nonulcerated cancer >15 mm, whereas in patients with similar lesions ≤15 mm, the ASGE suggests either ESD or EMR. The ASGE suggests against surgery for such patients with ESCC, whenever possible. For EAC, the ASGE suggests ESD over EMR for patients with early-stage, well-differentiated, nonulcerated cancer >20 mm, whereas in patients with similar lesions measuring ≤20 mm, the ASGE suggests either ESD or EMR. For GAC, the ASGE suggests ESD over EMR for patients with early-stage, well or moderately differentiated, nonulcerated intestinal type cancer measuring 20 to 30 mm, whereas for patients with similar lesions <20 mm, the ASGE suggests either ESD or EMR. The ASGE suggests against surgery for patients with such lesions measuring ≤30 mm, whereas for lesions that are poorly differentiated, regardless of size, the ASGE suggests surgical evaluation over endosic approaches.

Identifiants

pubmed: 37498265
pii: S0016-5107(23)00371-1
doi: 10.1016/j.gie.2023.03.030
pii:
doi:

Types de publication

Practice Guideline Review Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

285-305.e38

Informations de copyright

Copyright © 2023 American Society for Gastrointestinal Endoscopy. Published by Elsevier Inc. All rights reserved.

Auteurs

Mohammad A Al-Haddad (MA)

Division of Gastroenterology.

Sherif E Elhanafi (SE)

Division of Gastroenterology, Texas Tech University Health Sciences Center, Paul Foster School of Medicine, El Paso, Texas, USA.

Nauzer Forbes (N)

Department of Medicine; Department of Community Health Sciences.

Nirav C Thosani (NC)

Center for Interventional Gastroenterology (iGUT), McGovern Medical School, UTHealth, Houston, Texas, USA.

Peter V Draganov (PV)

Department of Gastroenterology.

Mohamed O Othman (MO)

Baylor College of Medicine, Houston, Texas, USA.

Eugene P Ceppa (EP)

Division of Surgical Oncology, Indiana University School of Medicine, Indianapolis, Indiana, USA.

Vivek Kaul (V)

Division of Gastroenterology and Hepatology, University of Rochester Medical Center, Rochester, New York, USA.

Michael M Feely (MM)

Department of Pathology.

Ilyas Sahin (I)

Division of Hematology and Oncology, Section of Gastroenterology, University of Florida, Gainesville, Florida, USA.

Yibing Ruan (Y)

Department of Oncology, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada; Department of Cancer Epidemiology and Prevention Research, Cancer Care Alberta, Alberta Health Services, Calgary, Alberta, Canada.

Behnam Sadeghirad (B)

Department of Health Research Methods, Evidence and Impact.

Rebecca L Morgan (RL)

Department of Health Research Methods, Evidence and Impact; Department of Anesthesia, McMaster University, Hamilton, Ontario, Canada; School of Medicine, Case Western Reserve University, Cleveland, Ohio, USA.

James L Buxbaum (JL)

Division of Gastrointestinal and Liver Diseases, Keck School of Medicine of the University of Southern California, Los Angeles, California, USA.

Audrey H Calderwood (AH)

Section of Gastroenterology and Hepatology, Department of Medicine, Geisel School of Medicine, Dartmouth-Hitchcock Medical Center, Lebanon, New Hampshire, USA.

Jean M Chalhoub (JM)

Division of Gastroenterology and Hepatology, Department of Medicine, Staten Island University Hospital, Northwell Health, Staten Island, New York, USA.

Nayantara Coelho-Prabhu (N)

Department of Gastroenterology, Mayo Clinic, Rochester, Minnesota, USA.

Madhav Desai (M)

Division of Gastroenterology, Hepatology and Nutrition, Department of Medicine, University of Minnesota Medical Center, Minneapolis, Minnesota, USA.

Larissa L Fujii-Lau (LL)

Gastroenterology Service, University of Hawaii, Honolulu, Hawaii, USA.

Divyanshoo R Kohli (DR)

Pancreas and Liver Clinic, Providence Sacred Heart Medical Center, Spokane, Washington, USA.

Richard S Kwon (RS)

Division of Gastroenterology and Hepatology, University of Michigan, Ann Arbor, Michigan, USA.

Jorge D Machicado (JD)

Division of Gastroenterology and Hepatology, University of Michigan, Ann Arbor, Michigan, USA.

Neil B Marya (NB)

Division of Gastroenterology and Hepatology, University of Massachusetts Medical Center, Worcester, Massachusetts, USA.

Swati Pawa (S)

Department of Medicine, Section on Gastroenterology, Wake Forest School of Medicine, Winston-Salem, North Carolina, USA.

Wenly Ruan (W)

Division of Pediatric Gastroenterology, Hepatology and Nutrition, Baylor College of Medicine, Texas Children's Hospital, Houston, Texas, USA.

Sunil G Sheth (SG)

Division of Gastroenterology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts, USA.

Andrew C Storm (AC)

Department of Gastroenterology, Mayo Clinic, Rochester, Minnesota, USA.

Nikhil R Thiruvengadam (NR)

Division of Gastroenterology and Hepatology, Loma Linda University, Loma Linda, California, USA.

Bashar J Qumseya (BJ)

Department of Gastroenterology.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH